Life360, Inc. 10-K

Item 9A. Controls and Procedures. Evaluation of Disclosure Controls and Procedures Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2025 pursuant to Rule 13a‑15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The term “disclosure controls and procedures” means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls, and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Based on such evaluation, our management concluded that our disclosure controls and procedures were effective as of December 31, 2025. Changes in Internal Control over Financial Reporting There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the year ended December 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Management’s Annual Report on Internal Control Over Financial Reporting Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2025 based on the guidelines established in the Internal Control—Integrated Framework ( 2013 ) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Our internal control over financial reporting includes policies and procedures that provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with GAAP. Based on the results of our evaluation, our management concluded that our internal control over financial reporting was effective as of December 31, 2025. Our independent registered public accounting firm, Deloitte & Touche LLP, has audited the consolidated financial statements included in this Annual Report and, as part of the audit, has issued an attestation report on the effectiveness of our internal control over financial reporting as of December 31, 2025, which is included below. 107 Table of Contents Limitations on the Effectiveness of Controls and Procedures Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls over financial reporting will prevent all errors and all fraud. A control system, no matter how well designed and implemented, can provide only reasonable, not absolute, assurance that the objectives of the control system will be met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues within a company are detected. The inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple errors or mistakes. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected. 108 Table of Contents Report of Independent Registered Public Accounting Firm To the stockholders and the Board of Directors of Life360, Inc. Opinion on Internal Control over Financial Reporting We have audited the internal control over financial reporting of Life360, Inc. and subsidiaries (the "Company") as of December 31, 2025, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO. We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2025, of the Company and our report dated March 2, 2026, expressed an unqualified opinion on those financial statements. Basis for Opinion T he Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. Definition and Limitations of Internal Control over Financial Reporting A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. /s/ Deloitte & Touche LLP San Francisco, California March 2, 2026 109 Table of Contents Item 9B. Other Information. Rule 10b5-1 Trading Plans Our directors and officers, subject to Rule 16a-1(f) of the Exchange Act, may from time to time enter into plans for the purchase or sale of our common stock that are intended to satisfy the affirmative defense in Rule 10b5-1(c) of the Exchange Act. During the three months ended December 31, 2025, the following directors and officers adopted or terminated a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K of the Exchange Act: Name Title Action Adoption Date Expiration Date Total number of securities to be sold Brit Morin Director Adoption 12/01/2025 12/31/2026 Up to 84,591 shares Lauren Antonoff Chief Executive Officer and Director Adoption 12/02/2025 12/31/2026 Up to 21,000 shares John Philip Coghlan Director Adoption 12/08/2025 12/01/2026 Up to 40,000 shares Chris Hulls Executive Chairman of the Board and Director Adoption 12/16/2025 04/26/2027 Up to 1,156,000 shares Alex Haro Director Adoption 12/16/2025 09/17/2026 Up to 200,000 shares Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. Not applicable. PART III Item 10. Directors, Executive Officers and Corporate Governance. The information required by this item will be contained in the Company’s Proxy Statement for its 2026 Annual Stockholder Meeting, to be filed with the SEC within 120 days after December 31, 2025 (the “2026 Proxy Statement”), under the headings “Proposal 1 — Election of Directors” and “Executive Officers” and is incorporated herein by reference . The information regarding compliance with Section 16(a) of the Exchange Act is incorporated by reference to the information set forth under the caption “Delinquent Section 16(a) Reports” in the 2026 Proxy Statement. Such information, if any, is incorporated herein by reference. We have adopted a code of conduct that applies to our directors, officers, and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. If we make any substantive amendments to the code of conduct or grant any waiver from a provision of the code of conduct to any executive officer or director, we will promptly disclose the nature of the amendment or waiver on our website. The full text of our code of conduct is on the investor relations portion of our website at investors.life360.com. The inclusion of our website address in this Annual Report on Form 10-K does not include or incorporate by reference into this Annual Report on Form 10-K the information on or accessible through our website. We have insider trading policies and procedures that govern the purchase, sale and other disposition of our securities by directors, officers, employees and contractors, as well as by the Company itself. We believe these policies and procedures are reasonably designed to promote compliance with insider trading laws, rules and regulations and listing standards applicable to the Company. A copy of our Insider Trading Policy is filed with this Annual Report on Form 10-K as Exhibit 19.1*. 110 Table of Contents Item 11. Executive Compensation. The information required by this item will be contained in the Company’s 2026 Proxy Statement, under the heading “Executive Compensation,” and is incorporated herein by reference . Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. The information required by this item will be contained in the Company’s 2026 Proxy Statement, under the heading “Security Ownership of Certain Beneficial Owners and Management,” and is incorporated herein by reference . Item 13. Certain Relationships and Related Transactions, and Director Independence. The information required by this item will be contained in the Company’s 2026 Proxy Statement, under the heading “Transactions with Related Persons and Indemnification,” and is incorporated herein by reference . Item 14. Principal Accountant Fees and Services. The information required by this item will be contained in the Company’s 2026 Proxy, under the heading “Principal Accountant Fees and Services,” and is incorporated herein by reference . 111 Table of Contents PART IV Item 15. Exhibits and Financial Statement Schedules. The following documents are filed as part of this Annual Report on Form 10-K: 1. Financial Statements. Our consolidated financial statements are listed in the “Index to Consolidated Financial Statements” under Part II, Item 8 of this Annual Report on Form 10-K. 2. Financial Statement Schedules. The financial statement schedules have been omitted as they are either not applicable or the required information is otherwise included. 3. Exhibits. The exhibits required to be filed as part of this report are listed in the Exhibit List attached hereto and are incorporated herein by reference. Incorporated by Reference Exhibit No. Description Filed Herewith Form File No. Filing Date Exhibit Number 3.1* Restated Certificate of Incorporation of the Company 8-K 000-56424 June 3, 2024 3.1 3.2* Amended and Restated Bylaws of the Company 8-K 000-56424 June 3, 2024 3.2 4.1†* Fourth Amended and Restated Investors’ Rights Agreement dated September 18, 2018, by and among Life360, Inc., the Founders, the Existing Preferred Holders and the New Investors 10-12G/A 000-56424 July 5, 2022 4.1 4.2* Description of Capital Stock 10-K 000-56424 February 29, 2024 4.2 4.3* Indenture, dated as of June 5, 2025, between Life360, Inc. and U.S. Bank Trust Company, National Association, as trustee. 8-K 001-42120 June 5, 2025 4.1 4.4* Form of certificate representing the 0.00% Convertible Senior Notes due 2030(included as Exhibit A to Exhibit 4.1). 8-K 001-42120 June 5, 2025 4.2 10.1+* Form of Indemnification Agreement between Life360 and its directors and officers 10-12G/A 000-56424 July 5, 2022 10.1 10.2+* Amended and Restated 2011 Stock Plan 10-12G/A 000-56424 July 5, 2022 10.2 10.3+* Form of Amended and Restated 2011 Stock Plan Restricted Stock Unit Agreement 10-K 000-56424 February 29, 2024 10.3 10.4+* Form of Amended and Restated 2011 Stock Plan Stock Option Agreement 10-K 000-56424 February 29, 2024 10.4 10.5+* Life360 Compensation Plan for Board Directors and Company Leadership 10-12G/A 000-56424 July 5, 2022 10.5 10.6+* Employment Agreement, dated May 14, 2019, between Life360, Inc. and Chris Hulls 10-12G/A 000-56424 July 5, 2022 10.6 112 Table of Contents 10.7§* Data Services and License Agreement, effective as of January 26, 2022, by and between Life360, Inc. and Placer Labs Inc. 10-12G/A 000-56424 July 5, 2022 10.13 10.8§ Amendment No. 1 to Data Services and License Agreement, effective as of June 8, 2022, by and between Life360, Inc. and Placer Labs Inc. 10-K 000-56424 February 29, 2024 10.12 10.9†§* Warranty Program Agreement, dated June 26, 2020, by and between Cover Genius Warranty Services, LLC and Tile, Inc. 10-12G/A 000-56424 July 5, 2022 10.15 10.10§* First Amendment to the Warranty Program Agreement, dated September 17, 2020, by and between Cover Genius Warranty Services, LLC and Tile, Inc. 10-12G/A 000-56424 July 5, 2022 10.16 10.11§* Second Amendment to the Warranty Program Agreement, dated October 8, 2021, by and between Cover Genius Warranty Services, LLC and Tile, Inc. 10-12G/A 000-56424 July 5, 2022 10.17 10.12* Vendor Terms and Conditions between Tile, Inc. and Amazon.com, effective June 4, 2018 10-12G/A 000-56424 July 5, 2022 10.35 10.13* Apple Developer Program License Agreement between Life360, Inc. and Apple Inc. 10-12G/A 000-56424 July 5, 2022 10.36 10.14* Schedules 2 and 3 to Apple Developer Program License Agreement between Life360, Inc. and Apple Inc. 10-12G/A 000-56424 July 5, 2022 10.37 10.15+ Form of Non-Executive Director Appointment Letter 10-K 000-56424 February 29, 2024 10.26 10.16* Form of 2023 Severance and Change in Control Plan 10-Q 000-56424 May 10, 2024 10.1 10.17+* Employment Agreement, dated May 11, 2020, by and between Life360, Inc. and Russell Burke 10-Q 000-56424 May 10, 2024 10.2 10.18+* Employment Agreement, dated May 2, 2023, by and between Life360, Inc. and Lauren Antonoff 10-Q 000-56424 May 10, 2024 10.3 10.19* Jabil Manufacturing Services Agreement, dated October 25, 2024, by and between Life360, Inc. and Jabil Inc., for itself and Jabil Circuit (Singapore) Pte. Ltd. 10-Q 0001-42120 November 12, 2024 10.1 10.20* Exclusivity and Revenue Share Agreement with Hubble Network Inc. 10-K 001-42120 February 27, 2025 10.31 10.21* Form of Capped Call Confirmations. 8-K 001-42120 June 5, 2025 10.1 10.22* Separation Agreement between Life360, Inc. and Susan Stick. 10-Q 001-42120 August 11, 2025 10.2 10.23* Consulting Agreement between Life360, Inc. and Susan Stick. 10-Q 001-42120 August 11, 2025 10.3 10.24+* Promotion Letter, dated August 8, 2025, between Life360, Inc. and Chris Hulls 10-Q 001-42120 November 10, 2025 10.1 113 Table of Contents 10.25+* Promotion Letter, dated August 8, 2025, between Life360, Inc. and Lauren Antonoff 10-Q 001-42120 November 10, 2025 10.2 10.26 A ddendum to Form of Amended and Restated 2011 Stock Plan Restricted Stock Unit Agreement X 10.27 Form of Amended and Restated 2011 Stock Plan Performance Restricted Stock Unit Agreement X 10.28 Form of Amended and Restated 2011 Stock Plan Performance R-TSR Restricted Stock Unit Agreement X 19.1* Insider Trading Policy 10-K 001-42120 February 27, 2025 19.1 21.1* List of Subsidiaries of the Company 10-12G/A 000-56424 July 5, 2022 21.1 23.1 Consent of Deloitte and Touche LLP, an Independent Registered Public Accounting Firm. X 24.1 Power of Attorney (included on the signature page to this report) X 31.1 Chief Executive Officer Certification Pursuant to Rule 13a-14(a) of the Exchange Act. X 31.2 Chief Financial Officer Certification Pursuant to Rule 13a-14(a) of the Exchange Act X 32.1 Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 X 32.2 Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 X 97.1* Incentive Compensation Recoupment Policy 10-K 001-42120 February 27, 2025 97.1 101.INS Inline XBRL Instance Document X 101.SCH Inline XBRL Schema Document X 101.CAL Inline XBRL Calculation Linkbase Document X 101.DEF Inline XBRL Definition Linkbase Document X 101.LAB Inline XBRL Label Linkbase Document X 101.PRE Inline XBRL Presentation Linkbase Document X 104 Cover Page Interactive Data (formatted as Inline XBRL and contained in Exhibit 101) X _____________________ * Filed previously. + Indicates a management contract or compensatory plan, contract or arrangement. 114 Table of Contents † Certain exhibits and schedules to this exhibit have been omitted in accordance with Item 601(a)(5) of Regulation S-K. The registrant hereby agrees to furnish supplementally a copy of any omitted exhibit or schedule to the SEC upon its request. § Portions of this exhibit have been redacted in accordance with Regulation S-K Item 601(b)(10)(iv). 115 Table of Contents Item 16. Form 10-K Summary None. 116 Table of Contents SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. LIFE360, INC. Dated: March 2, 2026 By: /s/ Lauren Antonoff Lauren Antonoff Chief Executive Officer and Director (Principal Executive Officer) Dated: March 2, 2026 By: /s/ Russell Burke Russell Burke Chief Financial Officer (Principal Financial and Accounting Officer) POWER OF ATTORNEY Each person whose individual signature appears below hereby authorizes and appoints Lauren Antonoff and Russell Burke, and each of them, with full power of substitution and resubstitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file any and all amendments to this report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue thereof. Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated. 117 Table of Contents Name Title Date /s/ Lauren Antonoff Chief Executive Officer and Director (Principal Executive Officer) March 2, 2026 Lauren Antonoff /s/ Russell Burke Chief Financial Officer (Principal Financial and Accounting Officer) March 2, 2026 Russell Burke /s/ Chris Hulls Executive Chairman of the Board and Director March 2, 2026 Chris Hulls /s/ Charles (CJ) Prober Director March 2, 2026 Charles (CJ) Prober /s/ John Philip Coghlan Director March 2, 2026 John Philip Coghlan /s/ Mark Goines Lead Independent Director March 2, 2026 Mark Goines /s/ Alex Haro Director March 2, 2026 Alex Haro /s/ Brit Morin Director March 2, 2026 Brit Morin /s/ James Synge Director March 2, 2026 James Synge /s/ David Wiadrowski Director March 2, 2026 David Wiadrowski /s/ Randi Zuckerberg Director March 2, 2026 Randi Zuckerberg 118